Byetta Pancreatitis Lawsuit Evaluations

Harvey Kirk

By Harvey Kirk
Posted August 21, 2008


The product liability lawyers at Saiontz & Kirk, P.A. are now reviewing and evaluating potential Byetta lawsuits for individuals diagnosed with pancreatitis after receiving the type 2 diabetes injection to help lower their blood glucose levels. Byetta has been associated with a number of reports of acute pancreatitis, hemorrhagic pancreatitis and necrotizing pancreatitis.


Our Byetta lawyers began investing and reviewing the potential for lawsuits in October 2007, after the FDA issued an alert warning about a possible association between Byetta and pancreatitis. At that time, the agency indicated that they had received reports of at least 30 cases of acute pancreatitis associated with the injection, and plans were announced to update the warning label to provide additional information about this potential Byetta side effect.

Earlier this week the FDA issued a second alert to provide additional information about the Byetta pancreatitis risk. They notified doctors that at least six new cases involving hemorrhagic pancreatitis or necrotizing pancreatitis have been reported among users of Byette. Two of those six died from the pancreatitis, and the four others were continuing to recovery as of Monday.

The FDA indicates that they are working with the drug makers, Amylin Pharmaceuticals, Inc. and Eli Lilly & Co. to make sure that stronger warnings about the pancreatitis side effects are placed more prominently on the label. For users who have developed pancreatitis, they may be entitled to compensation through a Byetta lawsuit as a result of the drug makers failure to adequately warn about this serious and potentially life threatening side effect.


If you, a friend or family member have been diagnosed with pancreatitis after taking the type 2 diabetes drug, you can now review your potential claim with a Byetta lawyer. All cases are being reviewed and investigated on a contingency fee basis, which means that there are no fees or expenses unless a recovery is obtained. Obtain a free Byetta lawsuit review.

4 Comments • Add Your Comments

  • James says:

    Hello. My mother passed away last year, due to necrotizing pancreatitis while taking Byetta. I have not signed papers yet, but am considering hiring another lawfirm to represent me in this case. Please contact me and advise if you believe it would be better for me to have your firm represent my case.
    Thank you!

    Posted on September 26, 2008 at 10:30 pm

  • garland says:

    I was a Januvia user when I contracted severe pancreatitis
    in feb 2008

    Posted on June 10, 2009 at 8:26 am

  • Harold says:

    My wife passed away on 5/15/’10. She was 38 & an autopsy was proformed the following Monday. No resaults yet (4 to 6 weeks) But she has been complaining she didn’t feel good but never said what or where. When I get the report of cause of death I will come back here. She WAS on Byette but hasn’t used it for 3 weeks. HAS been on it for 4 or 5 months. Not sure. She had type 2 diabetes & epilepsy.
    The PM said she may have blocked her air way & sufficated after having a seizure in the bathroom. Thank you. Harold.

    Posted on May 23, 2010 at 6:39 pm

  • Cheryl says:

    I have been on Byetta for almost 4 weeks……I started getting a bump at the injection sight……Then last night after my shot…..I broke out all over in huge red whelps…..I have pictures…..They itch….My glands in my nek are swollen……I have to wonder what damage was done to my body on the inside…..I reported it to the FDA website via Email…

    Posted on January 31, 2011 at 11:02 am

Add Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.